EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
116 hedge funds and large institutions have $667M invested in Eagle Pharmaceuticals, Inc. in 2016 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 45 increasing their positions, 28 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
116
Holders Change
-3
Holders Change %
-2.52%
% of All Funds
3.1%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
24
Increased
45
Reduced
28
Closed
26
Calls
$11.6M
Puts
$7.55M
Net Calls
+$4.09M
Net Calls Change
-$19.8M
Top Buyers
| 1 |
O
OrbiMed
New York
|
+$40.2M |
| 2 |
Morgan Stanley
New York
|
+$26.8M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$21.3M |
| 4 |
HEC
Hudson Executive Capital
New York
|
+$20.5M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$8.99M |
